Fisher DR - Search Results

1

Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.

Park SI, Shenoi J, Pagel JM, Hamlin DK, Wilbur DS, Orgun N, Kenoyer AL, Frayo S, Axtman A, Bäck T, Lin Y, Fisher DR, Gopal AK, Green DJ, Press OW. Park SI, et al. Among authors: fisher dr. Blood. 2010 Nov 18;116(20):4231-9. doi: 10.1182/blood-2010-05-282327. Epub 2010 Aug 11. Blood. 2010. PMID: 20702781 Free PMC article.

2

Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.

Sandmaier BM, Bethge WA, Wilbur DS, Hamlin DK, Santos EB, Brechbiel MW, Fisher DR, Storb R. Sandmaier BM, et al. Among authors: fisher dr. Blood. 2002 Jul 1;100(1):318-26. doi: 10.1182/blood-2001-12-0322. Blood. 2002. PMID: 12070043 Free article.

3

Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation.

Bethge WA, Wilbur DS, Storb R, Hamlin DK, Santos EB, Brechbiel MW, Fisher DR, Sandmaier BM. Bethge WA, et al. Among authors: fisher dr. Blood. 2003 Jun 15;101(12):5068-75. doi: 10.1182/blood-2002-12-3867. Epub 2003 Feb 27. Blood. 2003. PMID: 12609833 Free article.

4

High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.

Rajendran JG, Fisher DR, Gopal AK, Durack LD, Press OW, Eary JF. Rajendran JG, et al. Among authors: fisher dr. J Nucl Med. 2004 Jun;45(6):1059-64. J Nucl Med. 2004. PMID: 15181141 Free article. Clinical Trial.

5

Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma.

Rajendran J, Gopal A, Durack L, Fisher D, Press O, Eary J. Rajendran J, et al. Cancer Biother Radiopharm. 2004 Dec;19(6):738-45. doi: 10.1089/cbr.2004.19.738. Cancer Biother Radiopharm. 2004. PMID: 15665621

6

Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model.

Nemecek ER, Hamlin DK, Fisher DR, Krohn KA, Pagel JM, Appelbaum FR, Press OW, Matthews DC. Nemecek ER, et al. Among authors: fisher dr. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):787-94. Clin Cancer Res. 2005. PMID: 15701869

7

131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

Pagel JM, Appelbaum FR, Eary JF, Rajendran J, Fisher DR, Gooley T, Ruffner K, Nemecek E, Sickle E, Durack L, Carreras J, Horowitz MM, Press OW, Gopal AK, Martin PJ, Bernstein ID, Matthews DC. Pagel JM, et al. Among authors: fisher dr. Blood. 2006 Mar 1;107(5):2184-91. doi: 10.1182/blood-2005-06-2317. Epub 2005 Oct 27. Blood. 2006. PMID: 16254140 Free PMC article. Clinical Trial.

8

High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.

Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf SH, Maloney DG, Eary JF, Appelbaum FR, Press OW. Gopal AK, et al. Among authors: fisher dr. J Clin Oncol. 2007 Apr 10;25(11):1396-402. doi: 10.1200/JCO.2006.09.1215. Epub 2007 Feb 20. J Clin Oncol. 2007. PMID: 17312330

9

Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.

Nemecek ER, Green DJ, Fisher DR, Pagel JM, Lin Y, Gopal AK, Durack LD, Rajendran JG, Wilbur DS, Nilsson R, Sandberg B, Press OW. Nemecek ER, et al. Among authors: fisher dr. Cancer Biother Radiopharm. 2008 Apr;23(2):181-91. doi: 10.1089/cbr.2007.0433. Cancer Biother Radiopharm. 2008. PMID: 18454687

10

Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.

Pagel JM, Matthews DC, Kenoyer A, Hamlin DK, Wilbur DS, Fisher DR, Gopal AK, Lin Y, Saganic L, Appelbaum FR, Press OW. Pagel JM, et al. Among authors: fisher dr. Cancer Res. 2009 Jan 1;69(1):185-92. doi: 10.1158/0008-5472.CAN-08-2513. Cancer Res. 2009. PMID: 19118002 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters